Format

Send to

Choose Destination
Acta Oncol. 2017 Oct;56(10):1295-1301. doi: 10.1080/0284186X.2017.1314006. Epub 2017 Apr 19.

Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study.

Author information

1
a National Advisory Unit on Late Effects after Cancer Treatment , Oslo University Hospital , Oslo , Norway.
2
b Oslo University , Oslo , Norway.
3
c Division of Clinical Oncology , Østfold Hospital Trust , Kalnes , Norway.
4
d The Cancer Registry of Norway , Oslo , Norway.
5
e The Norwegian Radium Hospital, Department of Pathology , Oslo University Hospital , Oslo , Norway.
6
f The Norwegian Institute of Public Health , Bergen , Norway.

Abstract

BACKGROUND:

In patients with prostate cancer (PCa), the lack of clear guidelines on the use of radiotherapy after radical prostatectomy (RP) invites unwanted variation of this treatment. We describe the hazard ratios and probabilities related to the use of post-RP radiotherapy.

MATERIAL AND METHODS:

Data were collected from the Cancer Registry of Norway and nine radiotherapy units. All patients were diagnosed with a non-metastatic PCa from January 2004 through June 2011. Adjuvant radiotherapy was defined as pelvic radiotherapy initiated <5 months after RP at a PSA <0.2 ng/ml. All other pelvic radiotherapy series were categorized as salvage radiotherapy, and, combined with adjuvant radiotherapy they were termed post-RP radiotherapy.

RESULTS:

Of 6840 prostatectomized patients, 1170 (17%) had undergone post-RP radiotherapy, mainly as salvage radiotherapy. The number of adjuvant radiotherapy series almost tripled from 2009. Based on pre-prostatectomy variables (PSA, Gleason score, and clinical risk group) and findings in the prostatectomy specimens (status of resection margins, pathological tumor category and Gleason's score), the probability of post-RP radiotherapy ranged respectively from 14% to 73%, and from 4% to 83%.

CONCLUSIONS:

In our study, post-RP radiotherapy was applied in approximately one in six patients. Based on the combination of PCa-specific variables routinely available at the time of diagnosis, a patient's probability of post-RP radiotherapy can be determined before decision of primary treatment strategy, followed by probability determination based on histopathological variables emerging from the prostatectomy specimen.

PMID:
28422584
DOI:
10.1080/0284186X.2017.1314006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center